The effects of insulin-like growth factor binding protein-3 (IGFBP-3) on T47D breast cancer cells enriched for IGFBP-3 binding sites

Molecular and Cellular Biochemistry

Volumn 267, Issue 1-2, 2004, Pages 83-89

  Mishra, Suresh ^a   Murphy, Liam J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Growth inhibition; IGF independent effects; IGFBP 3

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; STREPTAVIDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOCRINE EFFECT; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PROTEIN CROSS LINKING; PROTEIN FUNCTION;

APOPTOSIS; BINDING SITES; BIOTINYLATION; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; TIME FACTORS;

EID: 9444251681     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000049368.40558.0a     Document Type: Article

References (16)

1. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16: 3-34, 1995
2. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mole Endocrinol 9: 361-367, 1996
3. Oh Y, Gucev Z, Ng L, Muller HL, Rosenfeld RG: Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog Growth Factor Res 6: 205-212, 1995
4. Lalou C, Lassarre C, Binoux MA: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137: 3206-3212, 1996
5. Hong J, Zhang G, Dong F, Rechler MM: Insulin-like growth factor (IGF) binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277: 10489-10497, 2002
6. Lalou C, Sawamura S, Segovia B, Ogawa Y, Binoux M: Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. C R Acad Sci III 320: 621-628, 1997
7. Zadeh SM, Binoux M: The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138: 3069-3072, 1997
8. Karas M, Danilenko M, Fishman D, LeRoith D, Levy J, Sharoni, Y: Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in Ishikawa endometrial cancer cells. J Biol Chem 272: 16514-16520, 1997
9. Oh Y, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268: 14964-14971, 1993
10. Ricort JM, Binoux M: Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. Endocrinology 142: 108-113, 2001
11. Lee KW, CohUn P: Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3. J Endocrinol 175: 33-40, 2002
12. Clemmons, DR: Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 22: 800-817, 2001
13. Hollowood AD, Stewart CE, Perks CM, Pell JM, Lai T, Alderson D, Holly JM: Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actions. J Cell Biochem 86: 583-589, 2002
14. Mangel WF, Toledo DL, Nardulli AM, Reiner GC, Norman MJ Katzenellenbogen BS: Plasminogen activators in human breast cancer c lines: Hormonal regulation and properties. J Steroid Biochem 30: 79-88, 1988
15. Mishra S, Murphy LJ: Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding. Endocrinology. 144: 4042-4050, 2003
16. Oh Y, Muller HL, Pham H, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268: 26045-26048, 1993